QSAM Biosciences Inc
QSAM
Get informed when a big investor buys or sells
+ FollowMarket Cap$18.44K
Close$
$0.45
94.5% downside
Current Fair Value
94.5% downsideOvervalued by 94.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $18,443.00 |
|---|---|
| Enterprise Value | $-1,360,444.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.24 |
| Beta | 1.81 |
| Outstanding Shares | 3,609,000 |
Return
| Return on Equity | -741.42% |
|---|---|
| Return on Assets | -292.33% |
| Return on Invested Capital | -586.97% |
Valuation & Multiples
| P/E Ratio | -6.67 |
|---|---|
| PEG | 9.18 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.34 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About QSAM Biosciences Inc
5 employees
CEO: J. Lloyd Breedlove